Please Update your browser
Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below. Just click on the icons to get to the download page.
Can't find what you're looking for?
Or continue login with
In a recent legal defense against a class action lawsuit, British-Swedish pharmaceutical firm AstraZ...
The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizati...
We cannot afford a repeat of trade barriers stopping the lion’s share of vaccines produced in ...
The effectiveness of COVID-19 vaccination typically decreases within six months of the administratio...
The decision underscores challenges many developing countries face in their slow inoculation campaig...
AstraZeneca said that a third, or "booster", dose of its Covid-19 vaccine Vaxzevria "...
Phase-three clinical trials conducted by AstraZeneca suggest that a single dose of the antibody comb...
The drug, called AZD7442, reduced the risk of developing severe COVID-19 or death by 50 percent in p...
The company said on Friday that 75 percent of the participants in the trial for the therapy - two ty...
The statement from the Anglo-Swedish company -- which produces its vaccine in Thailand for use domes...